MB

Megan Blewett

Founder of Iris Medicine

Berkeley, California

Overview 

Megan Blewett is the Co-founder and President of Iris Medicine, with a strong background in biochemistry, mass spectrometry, and bioinformatics. She has successfully co-founded and held leadership roles in multiple biotech companies, including Kelonia Therapeutics, and has experience as a life sciences investor at Venrock. Blewett's career highlights include co-founding Iris Medicine and Kelonia Therapeutics, showcasing her expertise in biotechnology and corporate development. As a seasoned professional in the San Francisco Bay Area, she has made significant contributions to the pharmaceutical and biotech sectors through her leadership roles and investments.

Work Experience 

IM

Iris Medicine

  • Co-Founder and President

    2024 - Current

  • Co-Founder and VP Corporate Development

    2021 - 2024

Iris Medicine focuses its services in the pharmaceutical and healthcare industry.

irismedicine.com
CR

Convergent Research

  • Board Member

    2022

Convergent Research is a focused research organization for conducting non-profit science projects and research.

Raised $1,967,868.00 from Alfred P. Sloan Foundation.

convergentresearch.org
KT

Kelonia Therapeutics

  • Co-Founder and Director of Business Development

    2019 - 2021

    Together with Venrock partner Bryan Roberts and scientific founders Michael Birnbaum and Michael Fischbach, I helped launch lentiviral gene therapy company Kelonia Therapeutics. The Birnbaum Lab had developed a highly elegant way to target lentiviruses to specific cell types, and it was our job to build a company leveraging this technology to treat serious diseases. Most of my time was focused on indication selection strategy and business development, but what I'm most proud of is helping to recruit the founding team.

Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.

Raised $50,000,000.00 from Alta Partners, Venrock and Horizons Ventures.

keloniatx.com
V

Venrock

  • Life sciences investor

    2017 - 2020

    - Board observer at Federation Bio, worked on company incubation and launch - Board observer at Prothelia - Co-founder at Iris Medicine - Co-founder at Kelonia Therapeutics

Venrock is a venture capital firm investing in technology and healthcare companies.

venrock.com

Education 

Articles About Megan

Relevant Websites